A summary of financial information of the Group with respect to the financial years ended 31 December 2006, 2007 and 2008 are indicated below:
Year ended
31 December
FY2008 (audited)
FY2007 (audited)
FY2006(1) (restated)
Results
of operations of the Group:
(US$
million)
Revenue
29,145.2
16,466.2
7,016.0
Cost of sales
(25,585.4)
(14,738.4)
(6,316.4)
Gross profit
3,559.8
1,727.8
699.6
Net gains arising from changes
in fair value of biological assets
0
123.5
17.4
Other operating income
277.4
133.0
46.3
Selling and distribution costs
(1,577.4)
(797.9)
(332.1)
Administrative expenses
(243.6)
(144.8)
(62.1)
Other operating expenses
(84.1)
(108.3)
(30.6)
Financial income
92.9
17.7
21.1
Finance expenses
(346.9)
(181.0)
(108.8)
Share of results of associates
111.2
59.8
37.9
Profit before tax
1,789.3
829.8
288.7
Tax expense
(232.1)
(154.6)
(32.3)
Profit for the year
1,557.2
675.2
256.4
Attributable to:
Equity holders of the Company
1,531.0
580.4
215.9
Minority interests
26.2
94.8
40.5
Basic
Earnings per Share (US cents per share)(2)(3)(4)
23.98
12.80
9.31
NOTES:
Year 2006 consolidated
figures have been restated to include full
12 months results of the IPT assets.
Basic Earnings per Share
for FY2006 has been computed based on the
net profit attributable to equity holders
and the weighted average number of shares
outstanding during financial year 2006 of
2,318,336,000 shares.
Basic Earnings per Share
for FY2007 has been computed based on the
net profit attributable to equity holders
and the weighted average number of shares
outstanding during financial year 2007 of
4,534,892,000 shares.
Basic Earnings per Share for FY2008 has been computed based on the net profit attributable to equity holders and the weighted average number of shares outstanding during financial year 2007 of 6,385,681,000 shares.
As at 31 December
Financial
Position of the Group(1):
(US$
million)
FY2008 (audited)
FY2007 (audited)
FY2006(1) (restated)
Non-Current
Assets
Property, plant and equipment
3,252.2
2,556.8
1,154.2
Investment securities
36.6
0.9
0.1
Investment in associates
1,157.9
452.0
184.4
Plasma investments
7.4
5.7
11.1
Biological assets
1,021.1
940.0
223.6
Intangible assets
3,942.0
3,933.3
38.0
Derivative financial instruments
14.2
33.6
0.6
Deferred tax assets
56.7
28.0
5.4
Other receivables
87.5
472.2
79.4
9,575.6
8,422.5
1,696.8
Current
Assets
Inventories
2,468.3
3,614.1
968.4
Trade receivables
1,331.2
1,501.2
467.4
Other receivables
746.0
856.5
404.6
Derivative financial instruments
816.1
95.9
17.0
Investment securities
38.6
49.2
0.1
Cash and cash equivalents
2,893.1
967.6
298.6
8,293.3
7,084.5
2,156.1
Total
Assets
17,868.9
15,507.0
3,852.9
Current liabilities
Trade payables
946.2
1,001.9
391.7
Other payables
894.2
780.3
187.5
Derivative financial instruments
289.6
108.0
17.5
Loans and borrowings
3,677.1
4,209.1
1,510.4
Tax payable
115.7
69.5
13.6
5,922.8
6,168.8
2,120.7
Non-current liabilities
Other payables
28.4
41.9
576.0
Loans and borrowings
1,606.4
818.7
114.8
Deferred tax liabilities
335.9
296.1
59.4
1,970.7
1,156.7
750.2
Total
Liabilities
7,893.5
7,325.5
2,870.9
Net
Assets
9,975.4
8,181.5
982.0
Represented
by:
Share capital
8,402.6
8,402.6
280.3
Retained earnings
2,321.7
1,095.8
547.2
Other reserves
(1,117.8)
(1,653.2)
29.8
9,606.5
7,845.2
857.3
Minority interests
368.9
336.3
124.7
Total
equity
9,975.4
8,181.5
982.0
Total
equity and liabilities
17,868.9
15,507.0
3,852.9
Net asset value per ordinary
share
(US cents per share)(2)(3)
150.44
122.86
33.86
NOTES:
The financial position
of the Group as at 31 December 2006 has been
restated to include IPT Assets.
Net asset value per ordinary
share as at 31 December 2006 has been computed
based on the share capital of 2,532,805,000
shares.
Net asset value per share as at 31 December 2007 & 2008 has been computed based on the share capital of 6,385,681,000 shares.
